Astrazeneca (AZN)

 

Latest News

Neil Woodford's trades in August 2017

After a busy summer for Neil Woodford, David Brenchley reveals what the star fund manager bought and sold last mon...

Be patient with Neil Woodford

Neil Woodford has come in for some criticism after his recent bad patch. Dzmitry Lipski asks whether his three funds ar...

Aspen acquires remaining rights to AZ anaesthetics

AstraZeneca has entered into an agreement for Aspen Global Incorporated to acquire the residual rights to the established ...

Broker Forecast - Liberum Capital issues a broker note on AstraZeneca PLC

Liberum Capital today downgrades its investment rating on AstraZeneca PLC (LON:AZN) to hold (from buy) and raised ...

All News

DateHeadlineSource
18-09-17Neil Woodford's trades in August 2017Interactive Investor
14-09-17Be patient with Neil Woodford Interactive Investor
14-09-17Aspen acquires remaining rights to AZ anaestheticsStockMarketWire
14-09-17Broker Forecast - Liberum Capital issues a broker note on AstraZeneca PLCStockMarketWire
14-09-17Aspen acquires remaining rights to AZ anaestheticsRNS
13-09-17Broker Forecast - JP Morgan Cazenove issues a broker note on AstraZeneca PLCStockMarketWire
11-09-17Stocks climb higher by the closeStockMarketWire
11-09-17Petra slumps as Provident ralliesStockMarketWire
11-09-17Broker Forecast - Bryan Garnier issues a broker note on AstraZeneca PLCStockMarketWire
11-09-17Broker Forecast - Jefferies International issues a broker note on AstraZeneca PLCStockMarketWire
11-09-17Petra plummets on export block by Tanzanian authoritiesStockMarketWire
11-09-17Broker Forecast - Deutsche Bank issues a broker note on AstraZeneca PLCStockMarketWire
11-09-17Tagrisso potential standard of care in lung cancerRNS
11-09-17IMFINZI superior PFS in Stage III lung cancerRNS
07-09-17Euro strong on European growth upgradeStockMarketWire
07-09-17Most-traded investments in August 2017Interactive Investor
07-09-17AZN trials placed on hold by FDAStockMarketWire
07-09-17Celgene and AZ update on Fusion trial programmeRNS
07-09-17Here's Neil Woodford's apology for dire performanceMoney Observer
07-09-17Shell and BP boost FTSEStockMarketWire
07-09-17Go-⁠Ahead operating profits fall as miners weakenStockMarketWire
07-09-17AZ reports positive study and trial results StockMarketWire
07-09-17AZ Duaklir improves lung function in COPD patientsRNS
07-09-17AZ tezepelumab cuts exacerbations in severe asthmaRNS
06-09-17Broker Forecast - Natixis issues a broker note on AstraZeneca PLCStockMarketWire
05-09-17Directorate ChangeRNS
04-09-17A small-cap pharma still smashing City forecastsInteractive Investor
01-09-17Total Voting RightsRNS
31-08-17Bulls in charge as FTSE recoversStockMarketWire
31-08-17FTSE back above 7,400StockMarketWire
30-08-17Broker Forecast - Goldman Sachs issues a broker note on AstraZeneca PLCStockMarketWire
29-08-17AZ breast cancer drug gets FDA approval StockMarketWire
29-08-17Faslodex gets US FDA OK for expanded use in breastRNS
24-08-17Broker Forecast - Jefferies International issues a broker note on AstraZeneca PLCStockMarketWire
22-08-17Stockwatch: Is this a coiled spring or a falling knife?Interactive Investor
21-08-17Tactical Asset Allocator: Emerging market exposure on the upMoney Observer
21-08-17Broker Forecast - Liberum Capital issues a broker note on AstraZeneca PLCStockMarketWire
18-08-17FTSE slumps as airlines remain weakStockMarketWire
18-08-17Tragic terror attack weighs on airlinesStockMarketWire
18-08-17FTSE falls after Barcelona terror attackStockMarketWire

RSS feeds

  • Editorial news feed for LSE:AZN Editorial
  • Regulatory news feed for LSE:AZN Regulatory